In the currently analyzed cohorts, CHEK2 p.(Asp438Tyr) carriers were identified in 0.7% of the cases with the indication of hereditary predisposition to disease and with similar frequency (0.6%) in the breast cancer cases unselected for family history or age at disease onset. The gene discussed is CHEK2; the disease is breast carcinoma.